1. Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas
   Christoph Treese et al, 2016, PLOS ONE CrossRef
2. The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants
   Xiang Tong et al, 2016, Scientific Reports CrossRef
3. The CXCL12 G801A Polymorphism Is Associated with Cancer Risk: A Meta-Analysis
   Ke Zhu et al, 2014, PLoS ONE CrossRef
4. Association of Survivin Promoter Polymorphisms with Inflammatory Bowel Disease and Response to Antitumor Necrosis Factor Therapy
   Emmanouela Rapti et al, 2015, Genetic Testing and Molecular Biomarkers CrossRef
5. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case–control studies
   Abdolkarim Moazeni-Roodi et al, 2019, International Journal of Clinical Oncology CrossRef
6. The survivin molecule as a double‐edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer
   Atieh Rafatmanesh et al, 2020, Journal of Cellular Physiology CrossRef
7. Survivin as a diagnostic and therapeutic marker for thyroid cancer
   Mohammad-Reza Mahmoudian-Sani et al, 2019, Pathology - Research and Practice CrossRef
8. Association of Survivin Polymorphisms with Tumor Susceptibility: A Meta-Analysis
   Ying Zhu et al, 2013, PLoS ONE CrossRef
9. MiR-20a-3p regulates TGF-β1/Survivin pathway to affect keratinocytes proliferation and apoptosis by targeting SFMBT1 in vitro
   Ronghua Li et al, 2018, Cellular Signalling CrossRef
10. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies
    Lei Xu et al, 2014, Tumor Biology CrossRef
11. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis
    Dan Meng et al, 2015, Journal of Huazhong University of Science and Technology [Medical Sciences] CrossRef
12. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies
    Qin Qin et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef